NASDAQ:ENVV

This Tiny Medical-Device Stock Is Back Above $11. Its Next FDA Test Is the Whole Trade
····

This Tiny Medical-Device Stock Is Back Above $11. Its Next FDA Test Is the Whole Trade

enVVeno Medical shares traded at $11.25 before Wednesday’s Nasdaq open, valuing the company at $7.4 million. The FDA has cleared enVVeno to begin its pivotal U.S. trial for enVVe, a non-surgical venous valve, with the first stage set to start later this year. The company reported $24.9 million in cash as of March 31, enough to fund operations into Q3 2027.
May 27, 2026

Stock Market Today

  • AnteoTech Applies for ASX Listing of 118 Million New Shares
    June 1, 2026, 8:37 PM EDT. AnteoTech Ltd has applied to the Australian Securities Exchange (ASX) for the official listing of 118,326,435 new fully paid ordinary shares. This move aims to enhance the company's capital structure and increase its public float. The application signals AnteoTech's intent to expand its shareholder base and support future growth initiatives. The shares will be quoted under the company's existing ticker symbol, AU:ADO.